DSM Integrated Annual Report 2021

Consolidated cash flow statement (Note 26)

x € million

 

2021

 

2020

 

 

 

 

 

Operating activities

 

 

 

 

Net profit for the year

 

1,680

 

508

Share of the profit of associates and joint ventures (including discontinued operations)1

 

(342)

 

32

Income tax (including discontinued operations)1

 

245

 

129

Profit before income tax expense (including discontinued operations)1

 

1,583

 

669

Financial income and expense (including discontinued operations)1

 

106

 

67

Operating profit (including discontinued operations)1

 

1,689

 

736

Depreciation, amortization and impairments (including discontinued operations)1

 

681

 

740

EBITDA (including discontinued operations)1

 

2,370

 

1,476

 

 

 

 

 

Adjustments for:

 

 

 

 

- (Gain) or loss from disposals

 

(649)

 

4

- Acquisition/divestment related in EBITDA

 

22

 

55

- Change in provisions

 

(20)

 

10

- Defined benefit plans

 

(39)

 

(13)

Adjustments for EBITDA

 

(686)

 

56

 

 

 

 

 

Income tax received

 

23

 

11

Income tax paid

 

(156)

 

(135)

Share-based compensation

 

22

 

29

Other

 

(2)

 

32

Adjustments for non-EBITDA

 

(113)

 

(63)

Operating cash flow before changes in working capital

 

1,571

 

1,469

 

 

 

 

 

Changes in operating working capital:

 

 

 

 

Inventories

 

(323)

 

(36)

Trade receivables

 

(194)

 

(4)

Trade payables

 

334

 

48

Changes in inventories, trade receivables and trade payables

 

(183)

 

8

Changes in non-operating working capital

 

39

 

17

Changes in working capital

 

(144)

 

25

Cash provided by operating activities

 

1,427

 

1,494

 

 

 

 

 

Investing activities

 

 

 

 

Capital expenditure for:2

 

 

 

 

- Intangible assets

 

(137)

 

(151)

- Property, plant and equipment

 

(433)

 

(458)

Payments regarding drawing rights

 

(7)

 

(17)

Proceeds from disposal of property, plant and equipment

 

27

 

1

Acquisition of subsidiaries and associates

 

(704)

 

(1,533)

Disposal of subsidiaries, businesses and associates

 

1,791

 

(2)

Additions to fixed-term deposits

 

(2,070)

 

(468)

Withdrawal from fixed-term deposits

 

1,625

 

1,114

Interest received

 

5

 

8

Other financial assets:

 

 

 

 

- Capital payments and acquisitions

 

(43)

 

(20)

- Dividends received

 

12

 

5

- Additions to loans granted

 

(10)

 

(9)

- Repayment of loans granted

 

29

 

1

- Proceeds from disposals

 

123

 

47

Cash from/(used in) investing activities

 

208

 

(1,482)

 

 

 

 

 

Financing activities

 

 

 

 

Contributions from Non-controlling interests

 

3

 

3

Acquisition of Non-controlling interests

 

(13)

 

(33)

Loans taken up

 

37

 

1,123

Repayment of loans

 

(513)

 

(268)

Payments of lease liabilities

 

(54)

 

(55)

Change in debt to credit institutions

 

12

 

(95)

Dividend paid

 

(266)

 

(289)

Interest paid

 

(65)

 

(54)

Proceeds from reissued treasury shares

 

34

 

63

Repurchase of shares

 

(165)

 

(309)

Other

 

6

 

(3)

Cash (used in)/from financing activities

 

(984)

 

83

 

 

 

 

 

Change in cash and cash equivalents

 

651

 

95

 

 

 

 

 

Cash and cash equivalents at 1 January

 

871

 

800

Exchange differences relating to cash held

 

39

 

(24)

Cash and cash equivalents at 31 December

 

1,561

 

871

1

The Consolidated cash flow statement includes an analysis of all cash flows in total, therefore including both continuing and discontinued operations. For the amounts related to discontinued operations split by activities and a reconciliation of profit from continuing operations to total, including discontinued operations, see Note 3 Change in the scope of consolidation.

2

In 2021, there was no customer funding of capital expenditures (in 2020 an amount of €24 million included in capital expenditure was funded by customers); all lease payments are recognized as cash used in financing activities.